Free public records show Xenon Pharmaceuticals Inc. in 6 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Xenon Pharmaceuticals Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
9 active studies led by Xenon Pharmaceuticals Inc., of 23 in all
Source: ClinicalTrials.gov, Studies with Xenon Pharmaceuticals Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Annual reports and other filings with the US Securities and Exchange Commission.
Source: SEC EDGAR, Company filings, CIK 1582313.
Studies Xenon Pharmaceuticals Inc. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Xenon Pharmaceuticals Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Xenon Pharmaceuticals Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Xenon Pharmaceuticals Inc. is in.
Stories on the topics Xenon Pharmaceuticals Inc. works in.
170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and…
Read
Depression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress…
Read
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
ReadSearch all reports for Xenon Pharmaceuticals Inc. All companies